Pipeline development
The latest news about Pipeline development: headlines, AI summaries and the full story from every source.
- Regeneron Forecasts Mid-Teens R&D Expense Growth for 2027 and $1B Sanofi Payment in Q4
- Incyte Provides 2026 Net Sales Outlook and Raises Opzelura Guidance
- Wave Life Sciences Announces Post-Incretin Maintenance Trial Timeline and Extended Cash Runway
- Bank of America Maintains Buy Rating on Merck Following Private Meeting with Chief Medical Officer
- Novo Nordisk Outlines Strategic Ambitions for Growth Through 2030
- Alberta Announces New Royalty Incentives to Boost Oil Production
- Saol Therapeutics Secures $115 Million Investment from Oaktree for SL1009 Launch Preparation
- Insmed's New Drug Launch Transforms Financial Performance
- Neurocrine Biosciences Reports Strong Q2 2026 Performance and Strategic Growth
- AbbVie Forecasts Adjusted EPS for 2026 Amid Strong Revenue Outlook
- Moderna Reports Q2 Earnings with Revenue Above Guidance and Narrowed Net Loss
- Alkermes Q2 2026 Earnings Call Summary: Strategic Growth, Pipeline Milestones
- Citizens Upgrades BeOne Medicines (ONC) Following Strong Clinical Data Presentation
- Post-War Oil Trade May Differ Significantly from Pre-Hormuz Closure Era
- Amylyx Pharmaceuticals Stock Rises on Pipeline Progress
- Novo Nordisk CEO States the Company is Actively Pursuing Deals to Strengthen Its Pipeline
- BioMarin Reports Q1 2026 Earnings with Revenue Growth and Guidance Update
- Ardelyx Reports Q1 2026 Earnings and Strategic Growth Initiatives
- Ardelyx Reports Q1 Revenue Growth and Provides Business Update
- DT Midstream Reports Q1 2026 Earnings with Increased Adjusted EBITDA and New Projects
- National Fuel Gas Reports Q2 2026 Earnings with Strong EPS Growth and Operational Adjustments
- Alnylam Pharmaceuticals Reports Strong Q1 Earnings with Revenue Growth and Pipeline Expansion
- Eli Lilly Reports Strong Q1 2026 Earnings and Announces New Obesity Drug Approval
- OPKO Health Q1 Earnings Call Highlights Progress in ModeX Pipeline and Financials
- GSK Reports Strong Q1 Earnings with Sales Growth and Guidance Reiteration
- Kiniksa Pharmaceuticals Reports Q1 Earnings and Raises 2026 Revenue Guidance
- Incyte Reports Strong Q1 2026 Earnings with Revenue Growth and Pipeline Progress
- Servier Completes Acquisition of Day One Biopharmaceuticals
- PureTech (PRTC) Q1 2025 Earnings Call Summary
- Amarin (AMRN) Reports Q3 2025 Earnings Results
- United Therapeutics Reports Q4 2025 Earnings with Revenue Growth and Pipeline Updates
- Navient Reports Q3 2025 Earnings Results
- Wells Fargo Upgrades Biogen to Overweight Amid Confidence in New Pipeline Programs
- Amphastar Pharmaceuticals Discusses Baqsimi and Primatene Growth at Needham Conference